Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study.

Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, Van Heertum RL, Arango V, Mann JJ.

Biol Psychiatry. 2006 Jan 15;59(2):106-13. Epub 2005 Sep 9.

PMID:
16154547
2.

Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality.

Miller JM, Brennan KG, Ogden TR, Oquendo MA, Sullivan GM, Mann JJ, Parsey RV.

Neuropsychopharmacology. 2009 Sep;34(10):2275-84. doi: 10.1038/npp.2009.54. Epub 2009 May 20.

3.

Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression.

Sullivan GM, Ogden RT, Oquendo MA, Kumar JS, Simpson N, Huang YY, Mann JJ, Parsey RV.

Biol Psychiatry. 2009 Aug 1;66(3):223-30. doi: 10.1016/j.biopsych.2009.01.028. Epub 2009 Mar 17.

4.

Imaging the serotonin 1A receptor using [11C]WAY100635 in healthy controls and major depression.

Hesselgrave N, Parsey RV.

Philos Trans R Soc Lond B Biol Sci. 2013 Feb 25;368(1615):20120004. doi: 10.1098/rstb.2012.0004. Print 2013. Review.

5.

Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635.

Bhagwagar Z, Rabiner EA, Sargent PA, Grasby PM, Cowen PJ.

Mol Psychiatry. 2004 Apr;9(4):386-92.

PMID:
15042104
6.

Genetic variation in brain-derived neurotrophic factor val66met allele is associated with altered serotonin-1A receptor binding in human brain.

Lan MJ, Ogden RT, Huang YY, Oquendo MA, Sullivan GM, Miller J, Milak M, Mann JJ, Parsey RV.

Neuroimage. 2014 Jul 1;94:33-9. doi: 10.1016/j.neuroimage.2014.02.027. Epub 2014 Mar 5.

7.

Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635.

Hirvonen J, Karlsson H, Kajander J, Lepola A, Markkula J, Rasi-Hakala H, NĂ¥gren K, Salminen JK, Hietala J.

Int J Neuropsychopharmacol. 2008 Jun;11(4):465-76. Epub 2007 Oct 31.

PMID:
17971260
8.

Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study.

Parsey RV, Olvet DM, Oquendo MA, Huang YY, Ogden RT, Mann JJ.

Neuropsychopharmacology. 2006 Aug;31(8):1745-9. Epub 2006 Jan 4.

9.

Higher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-100635.

Sullivan GM, Ogden RT, Huang YY, Oquendo MA, Mann JJ, Parsey RV.

Depress Anxiety. 2013 Mar;30(3):197-206. doi: 10.1002/da.22019. Epub 2013 Feb 13.

10.

Quantification of the Serotonin 1A Receptor Using PET: Identification of a Potential Biomarker of Major Depression in Males.

Kaufman J, Sullivan GM, Yang J, Ogden RT, Miller JM, Oquendo MA, Mann JJ, Parsey RV, DeLorenzo C.

Neuropsychopharmacology. 2015 Jun;40(7):1692-9. doi: 10.1038/npp.2015.15. Epub 2015 Jan 8.

11.

Serotonin-1A receptor imaging in recurrent depression: replication and literature review.

Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C.

Nucl Med Biol. 2007 Oct;34(7):865-77. Review.

12.

5-HT(1A) receptor binding in euthymic bipolar patients using positron emission tomography with [carbonyl-(11)C]WAY-100635.

Sargent PA, Rabiner EA, Bhagwagar Z, Clark L, Cowen P, Goodwin GM, Grasby PM.

J Affect Disord. 2010 Jun;123(1-3):77-80. doi: 10.1016/j.jad.2009.07.015. Epub 2009 Sep 2.

PMID:
19726088
13.

Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET.

Lanzenberger R, Baldinger P, Hahn A, Ungersboeck J, Mitterhauser M, Winkler D, Micskei Z, Stein P, Karanikas G, Wadsak W, Kasper S, Frey R.

Mol Psychiatry. 2013 Jan;18(1):93-100. doi: 10.1038/mp.2012.93. Epub 2012 Jul 3.

14.

Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder.

Sullivan GM, Oquendo MA, Milak M, Miller JM, Burke A, Ogden RT, Parsey RV, Mann JJ.

JAMA Psychiatry. 2015 Feb;72(2):169-78. doi: 10.1001/jamapsychiatry.2014.2406.

15.

Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder.

Miller JM, Hesselgrave N, Ogden RT, Zanderigo F, Oquendo MA, Mann JJ, Parsey RV.

Biol Psychiatry. 2013 Nov 15;74(10):760-7. doi: 10.1016/j.biopsych.2013.03.021. Epub 2013 May 9.

16.
17.

Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations.

Parsey RV, Ogden RT, Miller JM, Tin A, Hesselgrave N, Goldstein E, Mikhno A, Milak M, Zanderigo F, Sullivan GM, Oquendo MA, Mann JJ.

Biol Psychiatry. 2010 Jul 15;68(2):170-8. doi: 10.1016/j.biopsych.2010.03.023. Epub 2010 May 23.

18.

Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders.

Spindelegger C, Lanzenberger R, Wadsak W, Mien LK, Stein P, Mitterhauser M, Moser U, Holik A, Pezawas L, Kletter K, Kasper S.

Mol Psychiatry. 2009 Nov;14(11):1040-50. doi: 10.1038/mp.2008.35. Epub 2008 Mar 25.

PMID:
18362913
19.

Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635.

Frankle WG, Lombardo I, Kegeles LS, Slifstein M, Martin JH, Huang Y, Hwang DR, Reich E, Cangiano C, Gil R, Laruelle M, Abi-Dargham A.

Psychopharmacology (Berl). 2006 Dec;189(2):155-64. Epub 2006 Sep 5.

PMID:
16953380
20.

5-HT1A gene promoter polymorphism and [18F]MPPF binding potential in healthy subjects: a PET study.

Lothe A, Boni C, Costes N, Bouvard S, Gorwood P, Lavenne F, Alvarez M, Ryvlin P.

Behav Brain Funct. 2010 Jul 7;6:37. doi: 10.1186/1744-9081-6-37.

Supplemental Content

Support Center